​

Teva Pharmaceutical Industries Ownership | Who Owns Teva Pharmaceutical Industries?

OverviewForecastRevenueFinancialsChartTranscripts

Teva Pharmaceutical Industries Ownership Summary

Teva Pharmaceutical Industries is owned by 56.08% institutional investors, and 43.92% retail investors. Blackrock is the largest institutional shareholder, holding 3.83% of TEVA shares. Fidelity Contrafund is the top mutual fund, with 1.10% of its assets in Teva Pharmaceutical Industries shares.

TEVA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTeva Pharmaceutical Industries56.08%-43.92%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustrySpecialty & Generic Drug Manufacturers Stocks34.90%10.53%54.58%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock42.99M3.83%$698.55M
Fmr41.98M3.74%$682.15M
Ion asset management36.33M3.24%$590.36M
Clal insurance enterprises32.34M2.88%$525.67M
Migdal insurance & financial29.12M2.59%$473.17M
Menora mivtachim28.84M2.57%$468.62M
Exor capital llp26.46M2.36%$430.02M
Phoenix25.42M2.26%$413.12M
Slate path capital lp20.19M1.80%$328.11M
State street17.72M1.58%$287.99M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ion asset management36.33M32.96%$590.36M
Exor capital llp26.46M14.45%$430.02M
Tri locum partners lp2.55M10.48%$41.44M
Bridger management981.00K8.20%$15.94M
Migdal insurance & financial29.12M7.90%$473.17M
Parsifal capital management, lp6.70M7.85%$108.83M
Noked israel1.69M7.56%$27.38M
Rubric capital management lp17.26M7.35%$280.50M
Spartan fund management148.30K6.77%$2.41M
Phoenix25.42M6.33%$413.12M

Top Buyers

HolderShares% AssetsChange
Fmr41.98M0.04%20.73M
Morgan stanley13.14M0.02%7.71M
Arrowstreet capital, limited partnership5.80M0.08%4.57M
Invesco4.75M0.02%4.54M
Clal insurance enterprises32.34M5.50%3.54M

Top Sellers

HolderShares% AssetsChange
Phoenix25.42M6.33%-9.16M
Slate path capital lp20.19M6.25%-6.71M
Citigroup45.00K0.00%-6.18M
Alyeska investment group3.83M0.36%-2.52M
Ion asset management36.33M32.96%-2.25M

New Positions

HolderShares% AssetsChangeValue
Pointstate capital lp2.50M0.88%2.50M$40.63M
Noked israel1.69M7.56%1.69M$27.38M
Lord, abbett1.63M0.09%1.63M$26.54M
Driehaus capital management1.42M0.22%1.42M$23.12M
Norges bank1.07M0.00%1.07M$17.45M

Sold Out

HolderChange
Register financial advisors-29.00
St germain d j-37.00
Cassady schiller wealth management-37.00
Frazier financial advisors-37.00
Sugarloaf wealth management-58.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20245762.13%635,409,4364.34%561.94%264-1.49%1706.25%
Jun 30, 20245579.22%608,962,9466.60%542.10%2631.94%15925.20%
Mar 31, 20245106.47%571,233,553-1.26%501.91%25831.63%127-11.19%
Dec 31, 20234792.79%578,520,1014.69%512.12%1965.38%14311.72%
Sep 30, 20234660.43%552,618,94111.79%492.53%1863.91%128-8.57%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Contrafund12.45M1.10%42.37K
iShares Core MSCI EAFE ETF7.04M0.62%8.57K
Fidelity Contrafund Commingled Pl O5.16M0.46%244.15K
Fidelity Contrafund Commingled Pl S5.13M0.45%-30.56K
EAFE Equity Index Fund F4.77M0.42%161.86K
Fidelity Blue Chip Growth4.31M0.38%209.00K
iShares MSCI EAFE ETF3.70M0.33%-
Fidelity Advisor Equity Growth I3.67M0.32%-64.50K
Fidelity VIP Growth Initial3.50M0.31%-116.80K
Fidelity International Index3.46M0.31%53.73K

Recent Insider Transactions

DateNameRoleActivityValue
Nov 20, 2024Fox Christine EVP, Head of U.S. CommercialSell$327.09K
Aug 12, 2024Daniell Richard Exec. VP, European CommercialSell$1.71M
Aug 09, 2024Grant Angus EVP, Business DevelopmentSell$70.24K
Aug 09, 2024Hughes Eric A See "Remarks"Sell$782.97K
Aug 01, 2024Hughes Eric A See "Remarks"Sell$423.28K

Insider Transactions Trends

DateBuySell
2024 Q4-1
2024 Q3-4
2024 Q2-4
2024 Q1-16
2023 Q4--

TEVA Ownership FAQ

Who Owns Teva Pharmaceutical Industries?

Teva Pharmaceutical Industries shareholders are primarily institutional investors at 56.08%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Teva Pharmaceutical Industries's industry, Specialty & Generic Drug Manufacturers Stocks, is 34.90%, which Teva Pharmaceutical Industries exceeds.

Who owns the most shares of Teva Pharmaceutical Industries?

Teva Pharmaceutical Industries’s largest shareholders are Blackrock (42.99M shares, 3.83%), Fmr (41.98M shares, 3.74%), and Ion asset management (36.33M shares, 3.24%). Together, they hold 10.80% of Teva Pharmaceutical Industries’s total shares outstanding.

Does Blackrock own Teva Pharmaceutical Industries?

Yes, BlackRock owns 3.83% of Teva Pharmaceutical Industries, totaling 42.99M shares as of Jun 2024. This represents 0.02% of BlackRock's total assets, with a market value of 698.55M$. In the last quarter, BlackRock decreased its holdings by -717K shares, a -1.64% change.

Who is Teva Pharmaceutical Industries’s biggest shareholder by percentage of total assets invested?

Ion asset management is Teva Pharmaceutical Industries’s biggest shareholder by percentage of total assets invested, with 32.96% of its assets in 36.33M Teva Pharmaceutical Industries shares, valued at 590.36M$.

Who is the top mutual fund holder of Teva Pharmaceutical Industries shares?

Fidelity Contrafund is the top mutual fund holder of Teva Pharmaceutical Industries shares, with 1.10% of its total shares outstanding invested in 12.45M Teva Pharmaceutical Industries shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools